Access to treatment for Hepatitis C among injection drug users: results from the cross-sectional HOPE IV study

BACKGROUND: Evidence suggests that Greece is among the European countries with increased trend in HCV prevalence among injecting drug users (IDUs) from 2008 to 2014. Nonetheless, the access of IDUs to treatment for Hepatitis C Virus (HCV) is very limited while the risk of co-infection and transmissi...

Descripción completa

Detalles Bibliográficos
Autores principales: Souliotis, Kyriakos, Agapidaki, Eirini, Papageorgiou, Manto, Voudouri, Niki, Contiades, Xenophon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471999/
https://www.ncbi.nlm.nih.gov/pubmed/28615023
http://dx.doi.org/10.1186/s12939-017-0601-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471999/
https://www.ncbi.nlm.nih.gov/pubmed/28615023
http://dx.doi.org/10.1186/s12939-017-0601-3

Ejemplares similares